Skip to content
PhaSER Biomedical logo — Safe effective drugs in the real world

PhaSER Biomedical

Safe effective drugs in the real world

Founded 2022 United Kingdom Dundee, United Kingdom 3 employees Grant Total: $2.30M Biopharma, Health Care

General Information

Company Name PhaSER Biomedical
Founded Year 2022
Location United Kingdom Dundee, United Kingdom
Employees 3
Industries Biopharma, Health Care
Funding Stage Grant
Social

BounceWatch is an independent company data service, not affiliated with PhaSER Biomedical. To contact PhaSER Biomedical, visit phaserbio.com.

Is this your company?

Confirm with your work e-mail, get the Verified badge and keep this profile correct yourself. Search engines and AI assistants read it every day.

Get Verified

How does PhaSER Biomedical compare?

A PDF of PhaSER Biomedical and up to 10 competitors you pick: team, funding, traffic and every dated move of the last 90 days. Each company is re-checked on the day you order, so it is current.

See a sample report

This takes a few seconds: we look beyond our own index too.

Meeting PhaSER Biomedical soon?

A one-page PDF brief: what it does, key facts, the last 90 days of dated moves and questions worth asking. Re-checked on the day you order. See a sample

About PhaSER Biomedical

PhaSER Biomedical is a biopharma and healthcare startup established in 2022. The company's slogan, "Harnessing the potential of the 8HUM mouse model for comprehensive advancements in drug discovery and development," encapsulates its core mission. PhaSER Biomedical focuses on exploiting the 8HUM mouse, a unique mouse model with multiple utilities in drug discovery and development. On 19 February 2024, the Bill & Melinda Gates Foundation made a significant $2.30M grant investment in the company, affirming its potential in the field.

Business keywords: 8HUM mouse model, drug discovery, drug development, biomedical research, animal models, preclinical research, pharmaceuticals, genetic research, precision medicine

Funding Rounds & Investors (1)

View All
Funding Stage Amount Investors Lead Investors Date
Grant $2.30M 1
Bill & Melinda Gates Foundation
19 Feb 2024

PhaSER Biomedical Alternatives & Competitors

View All Alternatives
PhaSER Biomedical vs
Inoviv
Inoviv United Kingdom

Accelerating the Development of New Medicines with Targeted Proteomics

Venture round
34 employees
Biopharma, Biotechnology
PhaSER Biomedical vs
Galatea Bio Inc.
Galatea Bio Inc. United States

Harnessing diversity to advance biopharma discovery and precision medicine

Venture round
37 employees
AI, Big Data
PhaSER Biomedical vs

Cancer drug development comes of age.

Post-IPO Equity
190 employees
Biopharma, Biotechnology

FAQ About PhaSER Biomedical

Safe effective drugs in the real world
PhaSER Biomedical was founded in 2022.
PhaSER Biomedical is headquartered in Dundee, United Kingdom.
PhaSER Biomedical operates in Biopharma and Health Care. Its work centres on 8HUM mouse model, drug discovery, drug development and biomedical research.
PhaSER Biomedical has approximately 3 employees.
PhaSER Biomedical has completed 1 funding round, raising a total of $2.30M. The latest funding stage is Grant.
Top alternatives and competitors to PhaSER Biomedical include Inoviv, Galatea Bio Inc., Day One Biopharmaceuticals, VoxCell, Soricimed Biopharma Inc.. These companies operate in related industries and serve comparable markets. You can compare them side by side on Bounce Watch.
PhaSER Biomedical and Inoviv are both companies in similar industries. Compare their funding, team size, growth signals, and market position on Bounce Watch to see which one fits your needs.

Source: BounceWatch company record for PhaSER Biomedical, https://bouncewatch.com/company/phaser-biomedical, updated 30 December 2024. When citing, please name BounceWatch and link this page.

Analytics cookies (ours + Google). Cookie Policy

Talk to an analyst Book a 7-day Readout